Fortress Biotech (FBIO)
NASDAQ:FBIO

Fortress Biotech (FBIO) Stock Price & Analysis

1,007 Followers

FBIO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.48 - $2.16
Previous Close$0.93
Volume450.27K
Average Volume (3M)405.58K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-0.9
Beta0.60
Next EarningsMar 20, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-0.99
Shares Outstanding108,615,240
R-Squared0.13
Standard Deviation0.27
10 Day Avg. Volume646,152
30 Day Avg. Volume405,580
Price to Book (P/B)3.59
Price to Sales (P/S)1.89
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha-0.01
Number of Analyst Covering0


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

FBIO FAQ

What was Fortress Biotech’s price range in the past 12 months?
Fortress Biotech lowest stock price was $0.48 and its highest was $2.16 in the past 12 months.
    What is Fortress Biotech’s market cap?
    Currently, no data Available
    When is Fortress Biotech’s upcoming earnings report date?
    Fortress Biotech’s upcoming earnings report date is Mar 20, 2023 which is in 50 days.
      How were Fortress Biotech’s earnings last quarter?
      Fortress Biotech released its earnings results on Nov 14, 2022. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.27 by $0.02.
        Is Fortress Biotech overvalued?
        According to Wall Street analysts Fortress Biotech’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Fortress Biotech pay dividends?
          Fortress Biotech does not currently pay dividends.
          What is Fortress Biotech’s EPS estimate?
          Fortress Biotech’s EPS estimate is -$0.22.
            How many shares outstanding does Fortress Biotech have?
            Fortress Biotech has 108,615,240 shares outstanding.
              What happened to Fortress Biotech’s price movement after its last earnings report?
              Fortress Biotech reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.27. Following the earnings report the stock price went up 2.326%.
                Which hedge fund is a major shareholder of Fortress Biotech?
                Currently, no hedge funds are holding shares in FBIO

                ---

                Fortress Biotech Stock Smart Score

                5
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -52.25%
                12-Months-Change

                Fundamentals

                Return on Equity
                -118.18%
                Trailing 12-Months
                Asset Growth
                -20.66%
                Trailing 12-Months
                The Fortress Biotech stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Fortress Biotech

                Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales, Pharmaceutical and Biotechnology Product Development, and National. The National segment consists of National Holdings Corporation, an independent brokerage company. The company was founded on June 28, 2006 in and is headquartered in New York, NY.

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Armata Pharmaceuticals
                Eliem Therapeutics
                Pieris Pharmaceuticals
                Frequency Therapeutics
                SQZ Biotechnologies

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis